Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/780-sakk-2118-ribociclib-endocrine-combination-therapy-versus-chemotherapy-as-1st-line-treatment-in-patients-with-visceral-metastatic-breast-cancer-a-mul-ticenter-randomized-phase-iii-trial/authors